The Effects of Natesto For Treatment Of Hypogonadism
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
In this prospective study, the investigators plan is to confirm the role of Natesto
(intranasal testosterone) to combat hypogonadal symptoms in men trying to recover
spermatogenesis following the withdrawal of conventional Testosterone replacement therapy.